Key facts
as of Sep 2026- It has raised $410.3M across 2 recorded rounds; the latest was Later Stage VC ($51.3M) in Nov 2024.
- Notable investors include General Catalyst, Impact Assets, Insight Partners (New York), Fidelity Management & Research Company, Battery Ventures — 23 tracked in total.
- 3 institutional filers report fund marks on Cleerly across 15 filings.
- Cleerly has filed 1 Form D with the SEC, most recently Dec 2024 ($51.3M sold to 10 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Cleerly
Recorded secondary trades
No secondary trades in Cleerly shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
3 filers · latest Jun 20263 SEC-registered funds reported 15 fair-value marks on Cleerly between Apr 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
2 roundsAbout Cleerly
Developer of a healthcare platform designed to create a new standard of care for coronary artery disease. The company's platform has a non-invasive approach that supports the understanding of plaques and offers quantification and characterization of plaque buildup in the heart arteries, enabling healthcare providers to drastically improve the identification of at-risk patients for early treatment and prevention of heart attacks cost-effectively.
- Industry
- Decision/Risk Analysis
- Sector
- Healthcare
- HQ
- Denver, CO, United States
- Founded
- 2016
- Employees
- 235
- Website
- cleerlyhealth.com/
- Ownership
- Privately Held (backing)